ID   CLL-AAT
AC   CVCL_CY99
SY   CLL-MT
DR   Wikidata; Q54813640
RX   Patent=US8840885;
RX   PubMed=16418292;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3920.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
RX   Patent=US8840885;
RA   Bowdish K.S., McWhirter J.R.;
RT   "Methods for treating chronic lymphocytic leukemia.";
RL   Patent number US8840885, 23-Sep-2014.
//
RX   PubMed=16418292; DOI=10.1073/pnas.0510081103;
RA   McWhirter J.R., Kretz-Rommel A., Saven A., Maruyama T., Potter K.N.,
RA   Mockridge C.I., Ravey E.P., Qin F.-H., Bowdish K.S.;
RT   "Antibodies selected from combinatorial libraries block a tumor
RT   antigen that plays a key role in immunomodulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:1041-1046(2006).
//